Fanzor2

Structure of a eukaryotic CRISPR-Cas homolog, Fanzor2, shows its promise for gene editing

October 1, 2024

A revolution in biomedicine is currently underway, driven by the application of genome engineering tools such as the prokaryotic CRISPR-Cas9.…